Michael Powell is Founder at Apollo Longevity Institute and Chief Scientific Officer at DiaCarta, a research and development based biotech company pioneering the development and manufacturing of molecular diagnostic tests and other innovative technologies for the infectious disease, genomic and biopharmaceutical markets.